AXSM RSI Chart
Last 7 days
6.8%
Last 30 days
-13.1%
Last 90 days
5%
Trailing 12 Months
29.4%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2023 | 144.6M | 182.5M | 223.4M | 270.6M |
2022 | 0 | 0 | 0 | 50.0M |
2021 | 0 | 0 | 0 | 0 |
2020 | 0 | 0 | 0 | 0 |
2019 | 0 | 0 | 287.1K | 356.9K |
2018 | 209.7K | 212.3K | 214.8K | 217.4K |
2017 | 0 | 0 | 0 | 207.1K |
2016 | 1.8M | 1.4M | 914.0K | 474.3K |
2014 | 0 | 0 | 0 | 2.2M |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Mar 15, 2024 | jeffs roger | acquired | 70,198 | 29.91 | 2,347 | - |
Mar 15, 2024 | jeffs roger | sold | -168,062 | 71.6072 | -2,347 | - |
Mar 14, 2024 | jeffs roger | acquired | 719,787 | 24.0121 | 29,976 | - |
Mar 14, 2024 | jeffs roger | sold | -2,089,390 | 69.702 | -29,976 | - |
Sep 15, 2023 | coleman mark | acquired | 40,428 | 3.67 | 11,016 | - |
Sep 15, 2023 | coleman mark | sold | -828,241 | 75.1853 | -11,016 | - |
Sep 15, 2023 | coleman mark | sold | -1,396,190 | 75.1771 | -18,572 | - |
Jan 03, 2023 | coleman mark | acquired | 22,751 | 1.3 | 17,501 | - |
Mar 15, 2022 | coleman mark | acquired | 4,544 | 1.3 | 3,496 | - |
Nov 19, 2021 | jeffs roger | bought | 147,350 | 37.3038 | 3,950 | - |
Which funds bought or sold AXSM recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
Mar 22, 2024 | PNC FINANCIAL SERVICES GROUP, INC. | reduced | -0.32 | 50,551 | 424,533 | -% |
Mar 13, 2024 | MONECO Advisors, LLC | unchanged | - | 72,604 | 595,731 | 0.11% |
Mar 11, 2024 | VANGUARD GROUP INC | reduced | -0.87 | 33,597,000 | 294,226,000 | 0.01% |
Mar 01, 2024 | GOLDMAN SACHS GROUP INC | added | 158 | 21,631,700 | 32,761,600 | -% |
Feb 29, 2024 | Tortoise Investment Management, LLC | unchanged | - | 20,710 | 169,925 | 0.02% |
Feb 28, 2024 | AMERICAN INTERNATIONAL GROUP, INC. | added | 0.92 | 183,215 | 1,410,410 | 0.01% |
Feb 26, 2024 | Privium Fund Management B.V. | unchanged | - | 516,470 | 5,550,790 | 1.55% |
Feb 26, 2024 | Neo Ivy Capital Management | sold off | -100 | -204,000 | - | -% |
Feb 26, 2024 | Virtu Financial LLC | sold off | -100 | -956,000 | - | -% |
Feb 26, 2024 | PERCEPTIVE ADVISORS LLC | added | 115 | 48,953,500 | 82,615,900 | 1.84% |
Unveiling Axsome Therapeutics Inc's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Axsome Therapeutics Inc)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
MRNA | 42.3B | 6.8B | -8.96 | 6.17 | ||||
HILS | 22.4B | 152.6K | -2.4K | 146.8K | ||||
ALNY | 19.4B | 1.8B | -44.17 | 10.64 | ||||
BMRN | 16.7B | 2.4B | 99.73 | 6.91 | ||||
INCY | 12.8B | 3.7B | 21.46 | 3.47 | ||||
MID-CAP | ||||||||
APLS | 7.1B | 396.6M | -13.34 | 17.78 | ||||
BBIO | 5.4B | - | -8.31 | 60.35 | ||||
AXSM | 3.8B | 270.6M | -15.68 | 13.86 | ||||
ARWR | 3.6B | 240.7M | -11.98 | 14.77 | ||||
ACAD | 3.0B | 726.4M | -48.93 | 4.13 | ||||
SMALL-CAP | ||||||||
CPRX | 1.9B | 398.2M | 26.85 | 4.82 | ||||
NVAX | 678.8M | 983.7M | -1.25 | 0.69 | ||||
CRBP | 373.2M | 881.7K | -8.37 | 466.16 | ||||
INO | 304.5M | 4.9M | -2.25 | 62.57 | ||||
IBIO | 11.8M | 2.1M | -0.43 | 2.14 |
Axsome Therapeutics Inc News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q1 | 2019Q4 | 2019Q3 | 2018Q4 | 2018Q3 | 2018Q2 | 2018Q1 | 2017Q4 |
Revenue | 23.8% | 71,530,000 | 57,794,000 | 46,700,000 | 94,576,000 | 24,371,000 | 16,846,000 | 8,820,000 | - | - | - | - | - | - | - | - | 139,448 | - | 217,418 | 270,325 | 323,232 | 376,139 |
Costs and Expenses | 41.6% | 169,804,000 | 119,914,000 | 111,757,000 | 100,950,000 | 84,288,500 | 59,258,000 | 48,001,000 | 38,289,000 | 32,608,110 | 33,407,142 | 30,847,687 | - | - | - | - | - | - | - | - | - | - |
Operating Expenses | - | - | - | - | - | - | - | - | 38,288,872 | 32,608,040 | 33,407,142 | 30,847,687 | 27,844,061 | 27,744,236 | 32,491,457 | 24,428,170 | 18,947,235 | 9,450,315 | 8,243,459 | 7,989,593 | 7,163,210 | 6,444,120 |
S&GA Expenses | 4.4% | 86,809,000 | 83,188,000 | 78,935,000 | 74,191,000 | 61,498,000 | 40,892,000 | 31,160,000 | 25,704,000 | 18,826,383 | 20,226,884 | 16,344,361 | 11,248,372 | 10,359,507 | 4,970,057 | 5,222,899 | 3,111,662 | 2,299,083 | 2,202,679 | 2,439,061 | 2,410,699 | - |
R&D Expenses | 7.1% | 30,803,000 | 28,767,000 | 20,581,000 | 17,793,000 | 14,693,000 | 14,877,000 | 15,792,000 | 12,585,000 | 13,781,728 | 13,180,258 | 14,503,326 | 16,595,689 | 17,384,729 | 27,521,400 | 19,205,271 | 15,835,573 | 7,151,232 | 6,040,780 | 5,550,532 | 4,752,511 | - |
EBITDA Margin | 1.7% | -0.82 | -0.83 | -0.93 | -1.01 | -3.58 | -888 | -898 | -901 | -901 | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expenses | 2.9% | 4,868,000 | 4,730,000 | 3,916,000 | 3,216,000 | 2,569,000 | 2,531,000 | 1,467,000 | 1,119,000 | 1,142,917 | 1,169,166 | 1,169,167 | 1,143,750 | 917,955 | 379,167 | 308,339 | 383,334 | 186,941 | 182,357 | 195,801 | 206,867 | - |
Income Taxes | 52.1% | -325,000 | -678,000 | -617,000 | 2,580,000 | - | - | - | - | - | - | - | - | - | - | - | - | - | -217,418 | - | - | - |
Earnings Before Taxes | -57.4% | -98,976,000 | -62,877,000 | -67,787,000 | -8,638,000 | -61,241,000 | -44,823,000 | -41,438,000 | -39,632,000 | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBT Margin | 1.9% | -0.88 | -0.90 | -1.00 | -1.08 | -3.74 | -935 | -935 | -935 | -935 | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income | -58.6% | -98,651,000 | -62,199,000 | -67,170,000 | -11,218,000 | -61,240,500 | -44,823,000 | -41,439,000 | -39,632,000 | -33,976,144 | -34,882,677 | -32,284,209 | -29,259,970 | -29,164,647 | -32,484,146 | -24,806,984 | -19,135,612 | -9,597,015 | -8,281,974 | -8,280,916 | -4,805,559 | - |
Net Income Margin | 2.1% | -0.88 | -0.90 | -1.01 | -1.10 | -3.74 | -1,146 | -1,075 | -1,009 | -935 | -900 | -814 | -714 | - | - | - | - | - | - | - | - | - |
Free Cashflow | 43.7% | -30,369,000 | -53,919,000 | -55,482,000 | -5,892,000 | -27,743,907 | -22,824,000 | -33,778,000 | -32,867,000 | -28,840,519 | -27,034,880 | -25,412,430 | -27,245,484 | - | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Assets | -2.1% | 588 | 601 | 612 | 389 | 331 | 339 | 181 | 89.00 | 88.00 | 117 | 143 | 167 | 186 | 204 | 191 | 198 | 221 | 44.00 | 55.00 | 44.00 | 15.00 |
Current Assets | -1.5% | 504 | 512 | 520 | 304 | 246 | 252 | 104 | 87.00 | 87.00 | 115 | 142 | 165 | 184 | 203 | 191 | 198 | 220 | 44.00 | 55.00 | 44.00 | 15.00 |
Cash Equivalents | -7.3% | 386 | 417 | 437 | 247 | 201 | 228 | 73.00 | 85.00 | 86.00 | 115 | 141 | 165 | 184 | 202 | 191 | 197 | 220 | 44.00 | 54.00 | 43.00 | 14.00 |
Inventory | 51.6% | 15.00 | 10.00 | 9.00 | 8.00 | 4.00 | 2.00 | 10.00 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net PPE | -12.9% | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Goodwill | 0% | 12.00 | 12.00 | 12.00 | 10.00 | 10.00 | 12.00 | 12.00 | 12.00 | - | - | - | - | - | - | - | - | - | - | - | - | - |
Liabilities | 19.9% | 397 | 331 | 333 | 277 | 222 | 182 | 165 | 74.00 | 72.00 | 74.00 | 72.00 | 71.00 | 72.00 | 68.00 | 37.00 | 42.00 | 42.00 | 38.00 | 30.00 | 27.00 | 14.00 |
Current Liabilities | 21.1% | 139 | 115 | 115 | 101 | 97.00 | 60.00 | 43.00 | 25.00 | 23.00 | 25.00 | 23.00 | 22.00 | 23.00 | 20.00 | 23.00 | 26.00 | 24.00 | 19.00 | 13.00 | 8.00 | 11.00 |
Long Term Debt | 0.4% | 178 | 177 | 177 | 148 | 94.00 | 94.00 | 93.00 | 49.00 | 49.00 | 49.00 | 49.00 | 49.00 | 48.00 | 48.00 | 14.00 | 16.00 | 17.00 | 19.00 | 17.00 | 19.00 | 4.00 |
LT Debt, Current | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 7.00 | 5.00 | 3.00 | 1.00 | 2.00 | 1.00 | 3.00 |
LT Debt, Non Current | 0.4% | 178 | 177 | 177 | 148 | 94.00 | 94.00 | 93.00 | 49.00 | 49.00 | 49.00 | 49.00 | 49.00 | 48.00 | 48.00 | 14.00 | 16.00 | 17.00 | 19.00 | 17.00 | 19.00 | 4.00 |
Shareholder's Equity | -29.1% | 191 | 270 | 279 | 112 | 110 | 157 | 15.00 | 15.00 | 16.00 | 43.00 | 71.00 | 96.00 | 114 | 135 | 154 | 156 | 179 | 7.00 | 24.00 | 17.00 | 1.00 |
Retained Earnings | -13.4% | -835 | -736 | -674 | -607 | -596 | -535 | -490 | -448 | -409 | -375 | -340 | -308 | -278 | -249 | -226 | -208 | -175 | -151 | -132 | -118 | -107 |
Additional Paid-In Capital | 2.0% | 1,027 | 1,006 | 954 | 719 | 706 | 692 | 505 | 464 | 425 | 418 | 412 | 404 | 393 | 385 | 381 | 365 | 355 | 158 | 156 | 136 | 108 |
Shares Outstanding | 0.1% | 47.00 | 47.00 | 47.00 | 44.00 | 43.00 | 42.00 | 39.00 | 38.00 | 38.00 | 38.00 | 38.00 | 37.00 | - | - | - | - | - | - | - | - | - |
Float | - | - | - | 2,800 | - | - | - | 1,200 | - | - | - | 2,000 | - | - | - | 2,400 | - | - | - | 675 | - | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Cashflow From Operations | 43.3% | -30,362 | -53,548 | -55,349 | -5,821 | -27,563 | -22,758 | -33,537 | -32,653 | -28,840 | -26,776 | -25,393 | -27,215 | -20,553 | -15,734 | -18,895 | -23,273 | -17,567 | -10,626 | -8,681 | -9,499 | -9,793 |
Share Based Compensation | 27.5% | 18,915 | 14,840 | 15,922 | 12,943 | 10,768 | 9,198 | 10,162 | 7,598 | 5,890 | 5,725 | 5,456 | 3,731 | 5,606 | 2,869 | 4,148 | 2,134 | 2,814 | 1,156 | 889 | 1,256 | 353 |
Cashflow From Investing | 98.1% | -7.00 | -371 | -133 | -71.00 | -181 | -66.00 | -53,241 | -214 | -451* | -258 | -18.88 | -29.99 | -20.29 | -14.84 | -1.43 | -9.33 | -1.46 | -3.20 | - | - | - |
Cashflow From Financing | -100.0% | -2.00 | 33,370 | 246,080 | 51,565 | 1,066 | 176,950 | 75,464 | 31,102 | 691 | 439 | 1,971 | 8,029 | 2,090 | 27,428 | 12,265 | 630 | 193,893 | 519 | 19,822 | 38,155 | 8,542 |
Consolidated Statements of Operations - USD ($) $ in Thousands | 12 Months Ended | ||
---|---|---|---|
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Revenues [Abstract] | |||
Revenue | $ 270,600 | $ 50,037 | |
Operating expenses: | |||
Cost of revenue (excluding amortization and depreciation) | 26,065 | 5,198 | |
Research and development | 97,944 | 57,947 | $ 58,061 |
Selling, general and administrative | 323,123 | 159,254 | 66,646 |
Loss in fair value of contingent consideration | 48,918 | 3,298 | |
Intangible asset amortization | 6,375 | 4,139 | |
Total operating expenses | 502,425 | 229,836 | 124,707 |
Loss from operations | (231,825) | (179,799) | (124,707) |
Interest expense, net | (6,453) | (7,335) | (5,696) |
Loss before income taxes | (238,278) | (187,134) | (130,403) |
Income tax expense | (960) | ||
Net loss | $ (239,238) | $ (187,134) | $ (130,403) |
Net loss per common share, basic | $ (5.27) | $ (4.60) | $ (3.47) |
Net loss per common share, diluted | $ (5.27) | $ (4.60) | $ (3.47) |
Weighted average common shares outstanding, basic | 45,425,212 | 40,655,941 | 37,618,599 |
Weighted average common shares outstanding, diluted | 45,425,212 | 40,655,941 | 37,618,599 |
Product Sales | |||
Revenues [Abstract] | |||
Revenue | $ 202,460 | $ 50,037 | |
License Revenue | |||
Revenues [Abstract] | |||
Revenue | 65,735 | ||
Royalty Revenue | |||
Revenues [Abstract] | |||
Revenue | $ 2,405 |
Consolidated Balance Sheets - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 386,193 | $ 200,842 |
Accounts receivables, net | 94,820 | 37,699 |
Inventories, net | 15,135 | 4,320 |
Prepaid and other current assets | 8,115 | 2,781 |
Total current assets | 504,263 | 245,642 |
Equipment, net | 846 | 722 |
Right-of-use asset - operating lease | 6,772 | 420 |
Goodwill | 12,042 | 10,310 |
Intangible asset, net | 53,286 | 59,661 |
Non-current inventory and other assets | 11,027 | 14,721 |
Total assets | 588,236 | 331,476 |
Current liabilities: | ||
Accounts payable | 40,679 | 38,605 |
Accrued expenses and other current liabilities | 90,501 | 51,631 |
Operating lease liability, current portion | 1,267 | 425 |
Contingent consideration, current | 6,407 | 5,900 |
Total current liabilities | 138,854 | 96,561 |
Contingent consideration, non-current | 73,300 | 31,100 |
Loan payable, long-term | 178,070 | 94,259 |
Operating lease liability, long-term | 7,035 | |
Total liabilities | 397,259 | 221,920 |
Stockholders’ equity: | ||
Preferred stock, $0.0001 par value per share (10,000,000 shares authorized, none issued and outstanding) | ||
Common stock, $0.0001 par value per share (150,000,000 shares authorized, 47,351,363 and 43,498,617 shares issued and outstanding at December 31, 2023 and December 31, 2022, respectively) | 5 | 4 |
Additional paid-in capital | 1,026,543 | 705,885 |
Accumulated deficit | (835,571) | (596,333) |
Total stockholders’ equity | 190,977 | 109,556 |
Total liabilities and stockholders’ equity | $ 588,236 | $ 331,476 |